Search

everythinglearnresearchcommunity

for

Search:↓

People living with HIV in Turkey often have skin conditions, which are more common in advanced HIV stages and may help in diagnosing the infection.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Steroid treatment improved both gut and nerve symptoms in a man with Cronkhite–Canada syndrome.

Microneedles with extracellular vesicles show promise for treating various conditions with targeted delivery.

Research on the human skin microbiome has grown, focusing on skin health and diseases, with more studies needed on antibiotic resistance and AI applications.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

New drugs for heart disease may be developed from molecules secreted by stem cells.

Demodicosis should be considered in cats with facial skin issues exposed to inhalant glucocorticoids.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

HIV patients in Korea often have skin diseases like fungal infections, folliculitis, and seborrheic dermatitis, which are less common with effective HIV treatment.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Childhood cancer survivors need better skin care and sun protection.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Alitretinoin helped clear up a skin condition called generalized granuloma annulare in an elderly man.

No treatment showed clear superiority for lichen planopilaris.

Alopecia can be reversed with timely steroid treatment in VKH and SO diseases.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

A man with a weakened immune system was diagnosed with a rare skin condition called trichodysplasia spinulosa using skin examination techniques.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Thiopurines help treat IBD but require genetic testing to avoid side effects.